Comparison Overview

PharMerica

VS

Bristol Myers Squibb

PharMerica

805 N Whittington Pkwy, Louisville, 40222, US
Last Update: 2026-01-23
View Profile
Between 650 and 699
https://www.pharmerica.com/

Headquartered in Louisville, Kentucky, PharMerica is one of the largest institutional pharmacy companies in the U.S. With more than 180 long-term care pharmacies in almost every state, we offer a national scope with a local approach, as well as unmatched clinical quality and customer care. With approximately 6,000 dedicated employees, PharMerica is proud to be home to some of the industry’s best and brightest clinicians and innovators. Check out our current openings, ranging from long-term care pharmacy roles to corporate and other non-clinical opportunities. To support your quality of life, we offer educational opportunities, remote work, and a comprehensive benefits package.

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 3,204
Subsidiaries: 1
12-month incidents
0
Known data breaches
3
Attack type number
1
View Profile

Bristol Myers Squibb

3401 Princeton Pike, Lawrence Township, 08648, US
Last Update: 2026-01-18
Between 800 and 849
http://www.bms.com

At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 38,258
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
1

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/pharmerica.jpeg
PharMerica
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/bristol-myers-squibb.jpeg
Bristol Myers Squibb
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
PharMerica
100%
Compliance Rate
0/4 Standards Verified
Bristol Myers Squibb
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for PharMerica in 2026.

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for Bristol Myers Squibb in 2026.

Incident History — PharMerica (X = Date, Y = Severity)

PharMerica cyber incidents detection timeline including parent company and subsidiaries

Incident History — Bristol Myers Squibb (X = Date, Y = Severity)

Bristol Myers Squibb cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/pharmerica.jpeg
PharMerica
Incidents

Date Detected: 05/2023
Type:Breach
Attack Vector: Unauthorized Access
Blog: Blog

Date Detected: 3/2023
Type:Breach
Attack Vector: Hacking
Blog: Blog

Date Detected: 3/2023
Type:Breach
Attack Vector: External System Hacking
Blog: Blog
https://images.rankiteo.com/companyimages/bristol-myers-squibb.jpeg
Bristol Myers Squibb
Incidents

Date Detected: 5/2023
Type:Cyber Attack
Attack Vector: Malware
Blog: Blog

FAQ

Bristol Myers Squibb company demonstrates a stronger AI Cybersecurity Score compared to PharMerica company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

PharMerica company has faced a higher number of disclosed cyber incidents historically compared to Bristol Myers Squibb company.

In the current year, Bristol Myers Squibb company and PharMerica company have not reported any cyber incidents.

Neither Bristol Myers Squibb company nor PharMerica company has reported experiencing a ransomware attack publicly.

PharMerica company has disclosed at least one data breach, while the other Bristol Myers Squibb company has not reported such incidents publicly.

Bristol Myers Squibb company has reported targeted cyberattacks, while PharMerica company has not reported such incidents publicly.

Neither PharMerica company nor Bristol Myers Squibb company has reported experiencing or disclosing vulnerabilities publicly.

Neither PharMerica nor Bristol Myers Squibb holds any compliance certifications.

Neither company holds any compliance certifications.

PharMerica company has more subsidiaries worldwide compared to Bristol Myers Squibb company.

Bristol Myers Squibb company employs more people globally than PharMerica company, reflecting its scale as a Pharmaceutical Manufacturing.

Neither PharMerica nor Bristol Myers Squibb holds SOC 2 Type 1 certification.

Neither PharMerica nor Bristol Myers Squibb holds SOC 2 Type 2 certification.

Neither PharMerica nor Bristol Myers Squibb holds ISO 27001 certification.

Neither PharMerica nor Bristol Myers Squibb holds PCI DSS certification.

Neither PharMerica nor Bristol Myers Squibb holds HIPAA certification.

Neither PharMerica nor Bristol Myers Squibb holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

Improper validation of specified type of input in M365 Copilot allows an unauthorized attacker to disclose information over a network.

Published
Date
2026-01-22
Updated
Date
2026-01-22
Risk Information
cvss3
Base: 9.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:H/I:H/A:N
References
Description

Improper access control in Azure Front Door (AFD) allows an unauthorized attacker to elevate privileges over a network.

Published
Date
2026-01-22
Updated
Date
2026-01-22
Risk Information
cvss3
Base: 9.8
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
References
Description

Azure Entra ID Elevation of Privilege Vulnerability

Published
Date
2026-01-22
Updated
Date
2026-01-22
Risk Information
cvss3
Base: 9.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:L/A:N
References
Description

Moonraker is a Python web server providing API access to Klipper 3D printing firmware. In versions 0.9.3 and below, instances configured with the "ldap" component enabled are vulnerable to LDAP search filter injection techniques via the login endpoint. The 401 error response message can be used to determine whether or not a search was successful, allowing for brute force methods to discover LDAP entries on the server such as user IDs and user attributes. This issue has been fixed in version 0.10.0.

Published
Date
2026-01-22
Updated
Date
2026-01-22
Risk Information
cvss4
Base: 2.7
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:U/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

Runtipi is a Docker-based, personal homeserver orchestrator that facilitates multiple services on a single server. Versions 3.7.0 and above allow an authenticated user to execute arbitrary system commands on the host server by injecting shell metacharacters into backup filenames. The BackupManager fails to sanitize the filenames of uploaded backups. The system persists user-uploaded files directly to the host filesystem using the raw originalname provided in the request. This allows an attacker to stage a file containing shell metacharacters (e.g., $(id).tar.gz) at a predictable path, which is later referenced during the restore process. The successful storage of the file is what allows the subsequent restore command to reference and execute it. This issue has been fixed in version 4.7.0.

Published
Date
2026-01-22
Updated
Date
2026-01-22
Risk Information
cvss3
Base: 8.0
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:H/UI:N/S:C/C:H/I:H/A:H
References